Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 12.81
+0.13 (1.03%)
At close: Feb 27, 2026
21.84% (1Y)
| Market Cap | 5.02B +30.1% |
| Revenue (ttm) | 670.43M -4.0% |
| Net Income | 123.72M -24.6% |
| EPS | 0.32 -24.9% |
| Shares Out | 392.08M |
| PE Ratio | 40.59 |
| Forward PE | n/a |
| Dividend | 0.29 (2.25%) |
| Ex-Dividend Date | Apr 16, 2025 |
| Volume | 1,964,175 |
| Average Volume | 2,457,224 |
| Open | 12.70 |
| Previous Close | 12.68 |
| Day's Range | 12.70 - 12.85 |
| 52-Week Range | 10.16 - 18.38 |
| Beta | 0.40 |
| RSI | 55.78 |
| Earnings Date | Mar 20, 2026 |